Risk factors associated with in-hospital mortality for patients with ECLS due to postcardiotomy cardiogenic shock after isolated coronary surgery.


Journal

Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778

Informations de publication

Date de publication:
Jun 2022
Historique:
revised: 15 11 2021
received: 25 06 2021
accepted: 13 12 2021
pubmed: 6 1 2022
medline: 21 5 2022
entrez: 5 1 2022
Statut: ppublish

Résumé

Extracorporeal membrane oxygenation or extracorporeal life support (ECLS) in patients after cardiac surgery and postcardiotomy cardiogenic shock (PCS) is known to be associated with high mortality. Especially in patients after coronary artery bypass grafting (CABG) and PCS, ECLS is frequently established. The aim of this analysis was to evaluate factors associated with in-hospital mortality in patients treated with ECLS due to PCS after CABG. Between August 2006 and January 2017, 92 consecutive patients with V-A ECLS due to PCS after isolated CABG were identified and included in this retrospective analysis. Patients were divided into survivors (S) and non-survivors (NS) and analyzed with risk factors of in-hospital mortality. In-hospital mortality added up to 61 patients (66%). Non-survivors were significantly older (60 ± 812 (S) vs. 67 ± 10 (NS); p = 0.013). Bilateral internal mammary artery graft was significantly more frequently used in S (23% (S) vs. 2% (NS); p = 0.001). After 24 h of ECLS support, median lactate levels were significantly higher in NS (1.9 (1.3; 3.5) mmol/L (S) vs. 3.5 (2.1; 6.3) mmol/L (NS); p = 0.001). NS suffered more often acute kidney injury requiring dialysis (42% (S) vs. 74% (NS); p = 0.002). Mortality in patients with refractory PCS after CABG and consecutive ECLS support remains high. Failing end-organ recovery under ECLS despite optimized concomitant medical therapy is an indicator of adverse outcomes in this specific patient cohort. Moreover, total-arterial revascularization might be beneficial for cardiac recovery in patients suffering PCS after CABG and following ECLS.

Identifiants

pubmed: 34985129
doi: 10.1111/aor.14166
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1158-1164

Informations de copyright

© 2022 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.

Références

Gray BW, Haft JW, Hirsch JC, Annich GM, Hirschl RB, Bartlett RH. Extracorporeal life support: experience with 2000 patients. ASAIO J. 2015;61:2-7.
Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail. 2018;11:e004905.
Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139:302-11, 11.e1.
Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: risk factors for mortality. J Thorac Cardiovasc Surg. 2018;156:1894-902.e3.
Biancari F, Dalen M, Fiore A, Ruggieri VG, Saeed D, Jonsson K, et al. Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2020;159:1844-54.e6.
Wang L, Yang F, Wang X, Xie H, Fan E, Ogino M, et al. Predicting mortality in patients undergoing VA-ECLS after coronary artery bypass grafting: the REMEMBER score. Crit Care. 2019;23:11.
ELSO. Guidelines for adult cardiac failure. Ann Arbor, MI: Extracorporeal Life Support Organization; 2013.
Ghodsizad A, Koerner MM, Brehm CE, El-Banayosy A. The role of extracorporeal membrane oxygenation circulatory support in the “crash and burn” patient: from implantation to weaning. Curr Opin Cardiol. 2014;29:275-80.
Biancari F, Dalén M, Perrotti A, Fiore A, Reichart D, Khodabandeh S, et al. Venoarterial extracorporeal membrane oxygenation after coronary artery bypass grafting: results of a multicenter study. Int J Cardiol. 2017;241:109-14.
Hsu PS, Chen JL, Hong GJ, Tsai YT, Lin CY, Lee CY, et al. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg. 2010;37:328-33.
Pabst D, El-Banayosy A, Soleimani B, Brehm CE. Predictors of survival for nonhighly selected patients undergoing resuscitation with extracorporeal membrane oxygenation after cardiac arrest. ASAIO J. 2018;64:368-74.
Chen S-W, Tsai F-C, Lin Y-S, Chang C-H, Chen D-Y, Chou A-H, et al. Long-term outcomes of extracorporeal membrane oxygenation support for postcardiotomy shock. J Thorac Cardiovasc Surg. 2017;154:469-77.e2.
Sohail S, Fan E, Foroutan F, Ross HJ, Billia F, Alba AC. Predictors of mortality in patients treated with veno-arterial ECLS for cardiogenic shock complicating acute myocardial infarction: a systematic review and meta-analysis. J Cardiovasc Transl Res. 2021. Epub ahead of print.
Kowalewski M, Zieliński K, Brodie D, MacLaren G, Whitman G, Raffa GM, et al. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock-analysis of the extracorporeal life support organization registry. Crit Care Med. 2021;49:1107-117.
Chen F, Wang L, Shao J, Wang H, Hou X, Jia M. Survival following venoarterial extracorporeal membrane oxygenation in postcardiotomy cardiogenic shock adults. Perfusion. 2020;35:747-55.
Chung M, Zhao Y, Strom JB, Shen C, Yeh RW. Extracorporeal membrane oxygenation use in cardiogenic shock: impact of age on in-hospital mortality, length of stay, and costs. Crit Care Med. 2019;47:e214-21.
Samadashvili ZST, Wechsler A, Chikwe J, Adams DH, Smith CR, Jordan D, et al. Multiple versus single arterial coronary bypass graft surgery for multivessel disease. J Am Coll Cardiol. 2019;74:1275-85.
Taggart DP, Benedetto U, Gerry S, Altman DG, Gray AM, Lees B, et al. Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med. 2019;380:437-46.
Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J. 2013;34:112-20.
Combes A, Leprince P, Luyt C-E, Bonnet N, Trouillet J-L, Léger P, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med. 2008;36:1404-11.

Auteurs

Christian Jörg Rustenbach (CJ)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Ilija Djordjevic (I)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Lara David (L)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Borko Ivanov (B)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Stephen Gerfer (S)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Christopher Gaisendrees (C)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Stefanie Wendt (S)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Julia Merkle (J)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Joon Seo (J)

Department of Thoracic Surgery, Evangelical Hospital Herne, Herne, Germany.

Anton Sabashnikov (A)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Parwis Rahmanian (P)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Elmar Kuhn (E)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Axel Kroener (A)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Gerardus Bennink (G)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Kaveh Eghbalzadeh (K)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Thorsten Wahlers (T)

Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH